TYPE-1 DIABETES-MELLITUS AND HOMOCYST(E)INE

被引:0
|
作者
ROBILLON, JF
CANIVET, B
CANDITO, M
SADOUL, JL
JULLIEN, D
MORAND, P
CHAMBON, P
FREYCHET, P
机构
[1] CHU NICE,HOP LOUIS PASTEUR,DEPT BIOCHEM,F-06002 NICE 1,FRANCE
[2] CHU NICE,HOP LOUIS PASTEUR,DEPT CARDIOVASC DIS,F-06002 NICE 1,FRANCE
来源
DIABETES & METABOLISM | 1994年 / 20卷 / 05期
关键词
HOMOCYST(E)INE; TYPE 1 DIABETES (IDDM); ATHEROSCLEROSIS; VASCULAR RISK FACTOR;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
High Homocyst(e)ine levels (H) have been recently recognized as a risk factor for atherosclerosis. Patients with Diabetes Mellitus (DM) are prone to atherosclerosis. Therefore, this study was designed to search for the effect of DM on H and their relationship. Forty-one Type 1 diabetic subjects (DS, age 34.8 +/- 12 yr, DM duration : 10.7 +/- 11.1 yr) were compared to 40 age-matched control subjects (CS, age 34.2 +/- 9.1 yr). H (measured by ion-exchange chromatography, units : mu mol/l) and several parameters (creatininaemia; triglycerides; total, HDL, LDL cholesterol; Lp(a); HbA1c; vitamins B9 and B12) were determined after an overnight fast. H were significantly (p = 0.0001) lower in DS (6.8 +/- 2.2) than in CS (9.5 +/- 2.9). This difference was still apparent in male and female subgroups compared to matched CS (p = 0.003 for each). No correlation was found between H and : lipids, vitamins, renal or retinal status. But H seemed to increase with age, especially in women (p = 0.03; r = 0.32). While there is, at this time, no explanation for the lower H observed in DS, it appears that H cannot directly account for accelerated atherosclerosis in DM. Nevertheless, it remains to be established if high, or even normal, H could identify a subgroup of DS at higher risk of precocious and severe atherosclerosis.
引用
收藏
页码:494 / 496
页数:3
相关论文
共 50 条
  • [1] HOMOCYST(E)IN IN TYPE-1 DIABETES-MELLITUS
    ROBILLON, JF
    CANIVET, B
    CANDITO, M
    SADOUL, JL
    MORAND, P
    FREYCHET, P
    DIABETOLOGIA, 1993, 36 : A16 - A16
  • [2] DERMATOGLYPHICS IN TYPE-1 DIABETES-MELLITUS
    ZIEGLER, AG
    MATHIES, R
    ZIEGELMAYER, G
    BAUMGARTL, HJ
    RODEWALD, A
    CHOPRA, V
    STANDL, E
    DIABETIC MEDICINE, 1993, 10 (08) : 720 - 724
  • [3] AUTOANTIGENS IN TYPE-1 DIABETES-MELLITUS
    DOTTA, F
    ANASTASI, E
    TIBERTI, C
    DIMARIO, U
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1994, 17 (07) : 497 - 508
  • [4] GENETICS OF TYPE-1 DIABETES-MELLITUS
    BARNETT, AH
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 1992, 47 (07): : 513 - 517
  • [5] ALCOHOL AND TYPE-1 DIABETES-MELLITUS
    CHANTELAU, E
    SPRAUL, M
    GOSSERINGER, G
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1985, 110 (36) : 1393 - 1394
  • [6] Reduced total plasma homocyst(e)ine in children and adolescents with type 1 diabetes
    Wiltshire, E
    Thomas, DW
    Bagbursl, P
    Couper, J
    JOURNAL OF PEDIATRICS, 2001, 138 (06): : 888 - 893
  • [7] ISLET TRANSPLANTATION IN TYPE-1 DIABETES-MELLITUS
    ALEJANDRO, R
    BURKE, G
    SHAPIRO, ET
    NERY, J
    RICORDI, C
    MILLER, J
    MINTZ, DH
    CLINICAL RESEARCH, 1991, 39 (02): : A245 - A245
  • [8] IMMUNOLOGICAL DISORDERS OF TYPE-1 DIABETES-MELLITUS
    ZIEGLER, M
    ZIEGLER, B
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY, 1989, 94 (1-2): : 97 - 114
  • [9] IS PREVENTION OF TYPE-1 DIABETES-MELLITUS FEASIBLE
    THIVOLET, C
    DIABETES & METABOLISM, 1994, 20 (2BIS): : 235 - 239
  • [10] SPORT PRACTICE AND TYPE-1 DIABETES-MELLITUS
    GAUTIER, JF
    DIABETES & METABOLISM, 1994, 20 (04) : 439 - 442